Differentiating midazolam over-sedation from neurological damage in the intensive care unit
Critical Care2004Vol. 9(1), pp. R32–6
Citations Over TimeTop 15% of 2004 papers
Cathrine McKenzie, William McKinnon, Declan P. Naughton, David Treacher, Graham Davies, Gary Phillips, P. J. Hilton
Abstract
These findings confirm that prolonged sedation after midazolam therapy should be considered in the differential diagnosis of neurological damage in the ICU. This can be reliably detected by the assay method described. The effects of midazolam/1-OHMG persist days after administration of midazolam has ceased. After prolonged sedation has been excluded in this patient group, it is highly likely that neurological damage has occurred.
Related Papers
- → Propofol vs Midazolam for ICU Sedation(2001)413 cited
- → Conscious sedation during endoscopic retrograde cholangiopancreatography: midazolam or midazolam plus meperidine?(2007)26 cited
- → Comparison of sedation scores after nebulized and intravenous Midazolam in children(2018)3 cited
- A study of midazolam plasma concentrations in patients undergoing conscious sedation.(2010)
- → A Comparison of Patient Satisfaction with Two Commonly Used Sedation Regimens for Endoscopy(2011)